Metraipolis › archive › dc_8fbc325706fb
A next-generation anti-CTLA-4 probody mitigates toxicity and enhances anti-tumor immunity in mice — Europe PMC PMID:41073424
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41073424
- DOI
- 10.1038/s41467-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T10:01:39.495Z
- SHA-256 of the archived text
d344f27abba1948db94e0f43af26f2264a58a53c82b57993946203e390b3e404- Stable URL of this page
https://metraipolis.com/documento/dc_8fbc325706fb
How to cite
A next-generation anti-CTLA-4 probody mitigates toxicity and enhances anti-tumor immunity in mice — Europe PMC PMID:41073424 — Europe PMC (en), https://europepmc.org/article/MED/41073424 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8fbc325706fb (Metraipolis archive dc_8fbc325706fb, sha256 d344f27abba1948db94e0f43af26f2264a58a53c82b57993946203e390b3e404)
BibTeX
@misc{dc8fbc325706fb,
title = {A next-generation anti-CTLA-4 probody mitigates toxicity and enhances anti-tumor immunity in mice — Europe PMC PMID:41073424},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41073424},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8fbc325706fb; sha256 d344f27abba1948db94e0f43af26f2264a58a53c82b57993946203e390b3e404},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41073424. Agents can read the archived copy with the MCP tool read_document.